doi:10.1007/s00125-007-0899-2 31
The maintained improvement pattern suggests GHK-Cu successfully stimulated durable structural changes in dermal architecture supporting ongoing enhanced function without continuous peptide supplementation
These include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), tirzepatide (Mounjaro, Zepbounda dual GIP/GLP-1 agonist), exenatide (Byetta, Bydureon BCise), and lixisenatide (Adlyxin)
Its always important to consult with a healthcare provider before starting any new treatment, especially if you have pre-existing medical conditions or are taking other medications
These supplements are not as intense as GLP-1 medications, however, some contain ingredients that increase GLP-1 production in the body